This study is currently not recruiting participants.

A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

  • STATUS
    Not Recruiting
  • participants needed
    14
  • sponsor
    AstraZeneca
Updated on 19 May 2025
Accepts healthy volunteers
Online studies

Summary

The main purpose of this study is to assess the effect of food on balcinrenone/ dapagliflozin pharmacokinetics in fed and fasted state and pharmacokinetics of balcinrenone when dosed with a P-gp inhibitor in healthy participants.

Description

This study will be an open-label, randomised, 3-period, 3-treatment, single-dose, 3-way crossover study in healthy participants (males and females), performed at a single study site.

The study comprises of:

  • Screening period of 4 weeks within the interval of Day -28 and Day -2.
  • Three treatment periods during which participants will be residing at the Clinical Unit from the day before the first study intervention administration (Day -1). The participant will be discharged on Day 10.

    • Treatment A (reference, fasted), balcinrenone/dapagliflozin capsule dosed in the fasted state.
    • Treatment B (fed), balcinrenone/dapagliflozin capsule dosed together with food.
    • Treatment C (quinidine, fasted), balcinrenone/dapagliflozin capsule (dosed together with a P-gp inhibitor tablets (quinidine) in fasted state.

Participants will be randomised on Day 1 to one of the following 6 treatment sequences: ABC, ACB, BCA, BAC, CAB, or CBA. Each participant will receive all 3 treatments (A, B, and C) in the sequence participant was randomised to. Each treatment will be separated by a washout period of 72 hours; thus, each participant will receive study intervention on Day 1, Day 4, and Day 7.

• A final Follow-up Call within 5 - 7 days (Day 12-14) after the last study intervention administration.

Details
Condition Healthy Participants
Age 18years - 55years
Clinical Study IdentifierNCT06979388
SponsorAstraZeneca
Last Modified on19 May 2025

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.